CSE New Listing - Blueberries Medical Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2019) -  Blueberries Medical Corp. (CSE: BBM) is one of the latest new listing on the Canadian Securities Exchange, following the reverse take-over of CDN MSolar Corp. Blueberries Medical, through wholly-owned subsidiary Blueberries SAS, is seeking to become a large-scale producer of naturally grown premium quality cannabis in central Colombia.

InvestmentPitch Media has produced a "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Blueberries" in the search box.



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_6qv08l2y/Blueberries-Medical-Corp-CSEBBM-New-Listing

The property is located in the Bogota savannah, one of the safest areas in Colombia, and the major production center of cut flowers in Colombia. The company has pre-registered and owns 134 exclusive Colombian cannabis strains with high contents of CBD and THC. These strains have been tested by the company's master grower in different climates, altitudes and regions of Colombia.

Led by an expert team in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries SAS has received all the licences required for the cultivation, production, domestic distribution and international export of CBD and THC-based medical cannabis.

Blueberries will have an initial effective crop area of approximately 10,000 square meters, which is estimated to allow for production of over 5.4 tonnes of dry cannabis flower annually. Blueberries SAS anticipates generating its first commercial crop harvest during 2019 with commercial sale of CBD and THC cannabis oil extracts expected to be available for commercial sale during the second half of 2019.

The company has developed a cultivation model that will be scaled by including third party Contract Growers in order to increase the production available without the need for additional future capital investment.

Christian Toro, CEO, stated: "Our public listing in Canada marks the accomplishment of another important milestone for Blueberries as we continue to execute on our vision of becoming a leading producer of premium quality medicinal cannabis products internationally. Combining Canadian leadership in the cannabis industry, strategic global relationships and Colombian passion and expertise, at Blueberries Medical we do things better."

For more information please visit the company's website www.blueberriesmed.com, contact Camilo Villalba, COO, in Columbia at 57-1-345-5678 or email contacto@blueberriesmed.com.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/42749

info